Helsinki, Finland

Ruzica Kolakovic


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ruzica Kolakovic: Innovator in Drug Delivery Systems

Introduction

Ruzica Kolakovic is a notable inventor based in Helsinki, Finland, with a focus on advancements in drug delivery systems. With a passion for innovation, she aims to improve the efficiency of delivering bioactive agents to patients.

Latest Patents

Ruzica holds a patent for a "Drug delivery system for sustained delivery of bioactive agents." This innovative system includes a matrix made from nanofibrillated cellulose derived from plant-based materials, combined with at least one bioactive agent. Additionally, the system incorporates support materials selected from synthetic polymers, bio compounds, and natural polymers. The patent also covers methods for manufacturing the system and its various applications in medicine.

Career Highlights

Ruzica Kolakovic is currently employed at UPM-Kymmene Corporation, a leading company in the bioeconomy sector. Her work there is characterized by her dedication to research and development in sustainable technologies, particularly in healthcare applications.

Collaborations

Throughout her career, Ruzica has collaborated with several talented individuals, including Antti Laukkanen and Leena Peltonen. These partnerships have fostered a creative environment, enabling the exploration of new ideas and innovations in the field of drug delivery systems.

Conclusion

Ruzica Kolakovic is making significant strides in the realm of drug delivery innovation. Her patented system represents a leap forward in the effective delivery of therapeutic agents, showcasing her commitment to enhancing healthcare solutions. With her continued work in collaboration with esteemed colleagues, Ruzica is poised to further impact the field of biomedical engineering.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…